Andrew A. Voss, Ph.D.
|University of California, Davis, Davis, CA|
Area:Autisms, ryanodine receptor
Mean distance: 18.08 (cluster 6)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Hummel CS, Lu C, Loo DD, et al. (2011) Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2. American Journal of Physiology. Cell Physiology. 300: C14-21|
|Voss AA. (2009) Extracellular ATP inhibits chloride channels in mature mammalian skeletal muscle by activating P2Y1 receptors. The Journal of Physiology. 587: 5739-52|
|Voss AA, Allen PD, Pessah IN, et al. (2008) Allosterically coupled calcium and magnesium binding sites are unmasked by ryanodine receptor chimeras. Biochemical and Biophysical Research Communications. 366: 988-93|
|Voss AA, DÃez-Sampedro A, Hirayama BA, et al. (2007) Imino sugars are potent agonists of the human glucose sensor SGLT3. Molecular Pharmacology. 71: 628-34|
|Gao J, Voss AA, Pessah IN, et al. (2005) Ryanodine receptor-mediated rapid increase in intracellular calcium induced by 7,8-benzo(a)pyrene quinone in human and murine leukocytes. Toxicological Sciences : An Official Journal of the Society of Toxicology. 87: 419-26|
|Voss AA, Lango J, Ernst-Russell M, et al. (2004) Identification of hyperreactive cysteines within ryanodine receptor type 1 by mass spectrometry. The Journal of Biological Chemistry. 279: 34514-20|